Computer‐Aided Design of Self‐Assembled Nanoparticles to Enhance Cancer Chemoimmunotherapy via Dual‐Modulation Strategy
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202404261 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Xiaoting Shan und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203,…. Hauptthemen laut MEDLINE: Nanoparticles, Immunotherapy, Computer-Aided Design, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Rising-Star Program.
Abstract (Originalsprache)
The rational design of self‐assembled compounds is crucial for the highly efficient development of carrier‐free nanomedicines. Herein, based on computer‐aided strategies, important physicochemical properties are identified to guide the rational design of self‐assembled compounds. Then, the pharmacophore hybridization strategy is used to design self‐assemble nanoparticles by preparing new chemical structures by combining pharmacophore groups of different bioactive compounds. Hydroxychloroquine is grafted with the lipophilic vitamin E succinate and then co‐assembled with bortezomib to fabricate the nanoparticle. The nanoparticle can reduce M2‐type tumor‐associated macrophages (TAMs) through lysosomal alkalization and induce immunogenic cell death (ICD) and nuclear factor‐κB (NF‐κB) inhibition in tumor cells. In mouse models, the nanoparticles induce decreased levels of M2‐type TAMs, regulatory T cells, and transforming growth factor‐β (TGF‐β), and increase the proportion of cytotoxicity T lymphocytes. Additionally, the nanoparticles reduce the secretion of Interleukin‐6 (IL‐6) by inhibiting NF‐κB and enhance the programmed death ligand‐1 (PD‐L1) checkpoint blockade therapy. The pharmacophore hybridization‐derived nanoparticle provides a dual‐modulation strategy to reprogram the tumor microenvironment, which will efficiently enhance the chemoimmunotherapy against triple‐negative breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
- University of Chinese Academy of Sciences, No.19A Yuquan Road, Beijing, 100049, China.
- Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Shandong, 264000, China.
- Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, 264000, China.
- Precision Research Center for Refractory Diseases, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 201620, China.
ORCID-Profile: Yaping Li
Förderung
- National Natural Science Foundation of China
- Shanghai Rising-Star Program
Zitieren
APA
Shan, X., Cai, Y., Zhu, B., Sun, X., Zhou, L., Zhao, Z., Li, Y., & Wang, D. (2025). Computer‐Aided Design of Self‐Assembled Nanoparticles to Enhance Cancer Chemoimmunotherapy via Dual‐Modulation Strategy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202404261
Vancouver
Shan X, Cai Y, Zhu B, Sun X, Zhou L, Zhao Z, et al. Computer‐Aided Design of Self‐Assembled Nanoparticles to Enhance Cancer Chemoimmunotherapy via Dual‐Modulation Strategy. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202404261
BibTeX
@article{Shan2025,
author = {Shan, Xiaoting and Cai, Ying and Zhu, Binyu and Sun, Xujie and Zhou, Lingli and Zhao, Zhiwen and Li, Yaping and Wang, Dangge},
title = {Computer‐Aided Design of Self‐Assembled Nanoparticles to Enhance Cancer Chemoimmunotherapy via Dual‐Modulation Strategy},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202404261}
}
EUVIMED